EVALUATION OF SURVIVAL AND PROGNOSTIC FAC TORS OF 2,000 BRONCHOPULMONARY CANCERS REGISTERED DURING 10 YEARS IN AN ONCOLOGY DEPARTMENT

Two thousand lung cancer patients were registered at Grenoble's univer sity hospital joint oncology clinic from 1/1/1982 to 12/31/1991. These cases consisted of 443 small cell lung cancers (SCLC) and 1,551 non-s mall cell lung cancers (NSCLC). SCLC patients had a 4.6% and 2.9% surv ival rate at 5 and 10 years and only 7.2% of patients had a survival l onger than 30 months. The main prognostic factors for survival were ag e, sex, TNM stage and WHO performance status. There was no increase in survival during the 2 periods of the study. NSCLC patients had a 14% and 7% survival rate at 5 and 10 years Among 727 stage III or IV patie nts not treated with surgery, 2% were alive at 30 months. The main pro gnostic factors for survival were age, histology,TNM stage and WHO per formance status. There was no increase in survival during the 2 period s of the study.